Intracorporal injection of hSlo cDNA restores erectile capacity in STZ-diabetic F-344 rats in vivo

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 287, Issue 4 56-4, 2004, Pages

  Christ, George J ^a   Day, Nancy ^a   Santizo, Cristian ^a   Sato, Yoshi ^a   Zhao, Weixin ^a   Sclafani, Theresa ^a   Bakal, Ron ^a   Salman, Masha ^a   Davies, Kelvin ^a   Melman, Arnold ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Corporal smooth muscle; Erectile dysfunction; Gene transfer; Maxi K channel; Myocytes

Indexed keywords

COMPLEMENTARY DNA; HUMAN MAXI POTASSIUM CHANNEL PROTEIN; IBERIOTOXIN; NITROPRUSSIDE SODIUM; PROTEIN; STREPTOZOCIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CORPUS CAVERNOSUM; DOSE RESPONSE; ERECTILE DYSFUNCTION; GENE CONTROL; GENE EXPRESSION; GENE FUNCTION; GENE TRANSFER; HISTOPATHOLOGY; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; NERVE STIMULATION; NONHUMAN; PENIS ERECTION; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE TONE; STREPTOZOCIN DIABETES; TISSUE DISTRIBUTION;

ANIMALS; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; DNA, COMPLEMENTARY; GENE EXPRESSION; GENE THERAPY; IMPOTENCE; LARGE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS; MALE; POTASSIUM CHANNELS, CALCIUM-ACTIVATED; PRESSURE; RATS; RATS, INBRED F344;

EID: 4744354628     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00792.2003     Document Type: Article

References (38)

1. Abber JC, Lue TF, Orvis BR, McClure DR, and Williams RD. Diagnostic tests for impotence: a comparison of papaverine injection with the penile-brachial index and nocturnal penile tumescence monitoring. J Urol 135: 923-925, 1986.
2. Andersson KE. Erectile physiological and pathophysiological pathways involved in erectile dysfunction. J Urol 170: S6-S14, 2003.
3. Archer SL. Potassium channels and erectile dysfunction. Vasc Pharmacol 38: 61-71, 2002.
4. -· and improves erectile function in aged rats. Am J Physiol Heart Circ Physiol 284: H1408-H1421, 2003.
5. Bivalacqua TJ, Champion HC, Abdel-Mageed AB, Kadowitz PJ, and Hellstrom WJ. Gene transfer of prepro-calcitonin gene-related peptide restores erectile function in the aged rat. Biol Reprod 65: 1371-1377, 2001.
6. Bivalacqua TJ and Hellstrom WJG. Potential application of gene therapy for the treatment of erectile dysfunction. J Androl 22: 183-190, 2001.
7. Bivalacqua TJ, Usta M, Champion HC, Adams D, McNamara DB, Abdel-Mageed AB, Kadowitz PJ, and Hellstrom WJG. Gene transfer of endothelial nitric oxide synthase partially restores nitric oxide synthesis and erectile function in streptozotocin diabetic rats. J Urol 169: 1911-1917, 2003.
8. Blaivas JG, O'Donnell TF, Gottlieb P, and Labib KB. Comprehensive laboratory evaluation of impotent men. J Urol 124: 201-204, 1980.
9. + channel. Biophys J 63: 583-590, 1992.
10. Cellek Rodrigo S, R, Lobos E, Fernandez P, Serrano J, and Moncada S. Selective nitrergic neurodegeneration in diabetes mellitus-a nitric oxide-dependent phenomenon. Br J Pharmacol 128: 1804-1812, 1999.
11. Chancellor MB, Yoshimura N, Pruchnic R, and Huard J. Gene therapy strategies for urological dysfunction. Trends Mol Med 7: 301-306, 2001.
12. Chitaley K, Bivalacqua TJ, Champion HC, Usta MF, Hellstrom WJG, Mills TM, and Webb RC. Adeno-associated viral gene transfer of dominant negative RhoA enhances erectile function in rats. Biochem Biophys Res Commun 298: 427-432, 2002.
13. Christ GJ. Gene therapy for erectile dysfunction: where is it going? Curr Opin Urol 12: 497-501, 2002.
14. Christ GJ. K channels as molecular targets for the treatment of erectile dysfunction. J Androl 23: S10-S19, 2002.
15. Christ GJ. Frontiers in gene therapy. Int J Impot Res 15, Suppl 5: S33-S40, 2003.
16. Christ GJ, Rehman J, Day N, Salkoff L, Valcic M, Melman A, and Geliebter J. Intracorporal injection of hSlo cDNA in rats produces physiologically relevant alterations in penile function. Am J Physiol Heart Circ Physiol 275: H600-H608, 1998.
17. Costabile RA. Optimizing treatment for diabetes mellitus induced erectile dysfunction. J Urol 170: S35-S39, 2003.
18. Dow JA, Gluck RW, Golimbu M, Weinberg GI, and Morales P. Multiphasic diagnostic evaluation of arteriogenic, venogenic, and sinusoidogenic impotency. Value of noninvasive tests compared with penile duplex ultrasonography. Urology 38: 402-407, 1991.
19. Ca) channel in cultured human corporal smooth muscle cells. J Urol 153: 818-825, 1995.
20. Garcia ML, Gao Y, McManus OB, and Kaczorowski GL. Potassium channels: from scorpion venoms to high-resolution structure. Toxicon 39: 739-748, 2001.
21. Goldstein I, Siroky MB, Nath RL, McMillian TN, Menzolan JO, and Krane RJ. Vasculogenic impotence: role of the pelvic steal test. J Urol 128: 300-306, 1982.
22. Guay AT. Sexual dysfunction in the diabetic patient. Int J Impot Res 13: S47-S50, 2001.
23. Jevitch MJ. Importance of penile arterial pulse sound examination in impotence. J Urol 124: 820-824, 1980.
24. + channels and gap junctions in urogenital smooth muscle: implications for improved understanding of urogenital function, disease and therapy. Curr Drug Targets 2: 1-20, 2001.
25. Kim SC, Moon YT, and Oh CH. Non-visualization versus normal appearance of cavernous arteries on selective internal pudendal pharmacoangiograms: comparison with Duplex scanning, cavernosal artery systolic occlusion pressure and penile brachial index. Br J Urol 73: 185-189, 1994.
26. Korovkina VP and England SK. Detection and implications of potassium channel alterations. Vasc Pharmacol 38: 3-12, 2002.
27. Lawson K and Dunne MJ. Peripheral channelopathies as target for potassium channel openers. Expert Opin Investigat Drugs 10: 1345-1259, 2001.
28. Magee TR, Ferrini M, Garban HJ, Vernet D, Mitopni K, Rajfer J, and Gonzalez-Cadavid NF. Gene therapy of erectile dysfunction in the rat with penile neuronal nitric oxide synthase. Biol Reprod 67: 20-28, 2002.
29. + channel resistant to charybdotoxin and iberiotoxin. Proc Natl Acad Sci USA 97: 5562-5567, 2000.
30. Melman A and Christ GJ. Integrative erectile biology: the effects of age and disease on gap junctions and ion channels and their potential value to the treatment of erectile dysfunction. Urol Clin North Am 28: 217-231, 2001.
31. Melman A and Gingell JC. The epidemiology and pathophysiology of erectile dysfunction. J Urol 165: 5-11, 1999.
32. Melman A, Zhao W, Davies KP, Bakal R, and Christ GJ. The successful long-term treatment of age-related erectile dysfunction with hSlo cDNA in rats in vivo. J Urol 170: 285-290, 2003.
33. Rehman J, Chenven E, Brink PR, Grine B, Walcott B, Melman A, and Christ GJ. Diminished neurogenic- but not pharmacological-induced intracavernous pressure responses in the 3-mo STZ-diabetic rat. Am J Physiol Heart Circ Physiol 272: H1960-H1971, 1997.
34. Schenk G, Melman A, and Christ GJ. Gene therapy: future therapy for erectile dysfunction. Curr Urol Rep 2: 480-487, 2001.
35. Schwartz AN, Lowe MA, Ireton R, Berger Richardson RE, ML, and Graney DO. A comparison of penile brachial index and angiography: evaluation of corpora cavernosa arterial inflow. J Urol 143: 510-513, 1990.
36. Sobey CG. Potassium channel function in vascular disease. Arterioscler Thromb Vasc Biol 21: 28-38, 2001.
37. Tirney S, Mattes CE, Yoshimura N, Yokoyama T, Ozawa H, Tzeng E, Birder LA, Kanai AJ, Huard J, de Groat WC, and Chancellor MB. Nitric oxide synthase gene therapy for erectile dysfunction: comparison of plasmid adenovirus, and adenovirus-transduced myoblast vectors. Mol Urol 5: 37-43, 2001.
38. ATP channel openers. J Urol 168: 355-361, 2002.